Free Trial
NASDAQ:SNES

SenesTech (SNES) Stock Price, News & Analysis

SenesTech logo
$1.47 -0.17 (-10.09%)
Closing price 04/4/2025 03:59 PM Eastern
Extended Trading
$1.71 +0.24 (+16.33%)
As of 04/4/2025 06:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About SenesTech Stock (NASDAQ:SNES)

Key Stats

Today's Range
$1.36
$1.64
50-Day Range
$1.47
$3.50
52-Week Range
$1.36
$9.80
Volume
49,617 shs
Average Volume
77,931 shs
Market Capitalization
$2.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00
Consensus Rating
Buy

Company Overview

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Remove Ads

SenesTech Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
36th Percentile Overall Score

SNES MarketRank™: 

SenesTech scored higher than 36% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    SenesTech has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    SenesTech has received no research coverage in the past 90 days.

  • Read more about SenesTech's stock forecast and price target.
  • Earnings Growth

    Earnings for SenesTech are expected to grow in the coming year, from ($10.22) to ($6.24) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of SenesTech is -0.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of SenesTech is -0.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    SenesTech has a P/B Ratio of 0.12. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about SenesTech's valuation and earnings.
  • Percentage of Shares Shorted

    17.29% of the float of SenesTech has been sold short.
  • Short Interest Ratio / Days to Cover

    SenesTech has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in SenesTech has recently increased by 83.30%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    SenesTech does not currently pay a dividend.

  • Dividend Growth

    SenesTech does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    17.29% of the float of SenesTech has been sold short.
  • Short Interest Ratio / Days to Cover

    SenesTech has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in SenesTech has recently increased by 83.30%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    SenesTech has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for SenesTech this week, compared to 1 article on an average week.
  • MarketBeat Follows

    Only 1 people have added SenesTech to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, SenesTech insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 9.99% of the stock of SenesTech is held by insiders.

  • Percentage Held by Institutions

    Only 5.19% of the stock of SenesTech is held by institutions.

  • Read more about SenesTech's insider trading history.
Receive SNES Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SenesTech and its competitors with MarketBeat's FREE daily newsletter.

SNES Stock News Headlines

Trump Treasure April 19
Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…
SenesTech reports Q4 EPS ($1.22) vs. ($48.68) last year
SenesTech announces additional operating optimization initiatives
See More Headlines

SNES Stock Analysis - Frequently Asked Questions

SenesTech's stock was trading at $3.31 at the start of the year. Since then, SNES shares have decreased by 55.6% and is now trading at $1.47.
View the best growth stocks for 2025 here
.

SenesTech, Inc. (NASDAQ:SNES) issued its earnings results on Wednesday, March, 12th. The company reported ($1.22) EPS for the quarter, beating the consensus estimate of ($1.50) by $0.28. The business earned $0.50 million during the quarter, compared to analysts' expectations of $0.71 million. SenesTech had a negative trailing twelve-month return on equity of 150.33% and a negative net margin of 403.51%.

SenesTech shares reverse split before market open on Thursday, July 25th 2024. The 1-10 reverse split was announced on Tuesday, July 23rd 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, July 24th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

SenesTech (SNES) raised $15 million in an initial public offering on Thursday, December 8th 2016. The company issued 1,900,000 shares at $8.00 per share. Roth Capital Partners served as the underwriter for the IPO and Craig-Hallum Capital Group was co-manager.

Shares of SNES stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that SenesTech investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CymaBay Therapeutics (CBAY), General Electric (GE), Arista Networks (ANET) and Adobe (ADBE).

Company Calendar

Last Earnings
3/12/2025
Today
4/05/2025
Next Earnings (Estimated)
5/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Agricultural chemicals
Sub-Industry
Chemicals
Current Symbol
NASDAQ:SNES
Fax
N/A
Employees
30
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$10.00
High Stock Price Target
$10.00
Low Stock Price Target
$10.00
Potential Upside/Downside
+580.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-7,710,000.00
Net Margins
-403.51%
Pretax Margin
-403.51%

Debt

Sales & Book Value

Annual Sales
$1.86 million
Price / Cash Flow
N/A
Book Value
$12.36 per share
Price / Book
0.12

Miscellaneous

Free Float
931,000
Market Cap
$2.57 million
Optionable
Not Optionable
Beta
-0.03

Social Links

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report

This page (NASDAQ:SNES) was last updated on 4/5/2025 by MarketBeat.com Staff
From Our Partners